The Company’s current investors include:

Abingworth Management
www.abingworth.com

Cancer Research Technology
www.cancertechnology.com

Essex Woodlands Healthcare Ventures
www.essexwoodlands.com

Gilde Investment Management
www.gilde.nl

GSK
www.gsk.com

Phase4 Ventures
www.phase4ventures.com

The Institute of Cancer Research
www.icr.ac.uk

The University of Cambridge
www.cam.ac.uk

The Wellcome Trust
www.wellcome.ac.uk